Compare ANIP & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIP | EFSC |
|---|---|---|
| Founded | 2001 | 1988 |
| Country | United States | United States |
| Employees | N/A | 1418 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 1999 | N/A |
| Metric | ANIP | EFSC |
|---|---|---|
| Price | $79.75 | $67.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $110.00 | $66.33 |
| AVG Volume (30 Days) | ★ 237.0K | 214.3K |
| Earning Date | 05-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.36% |
| EPS Growth | ★ 419.23 | N/A |
| EPS | ★ 1.28 | N/A |
| Revenue | ★ $206,547,000.00 | N/A |
| Revenue This Year | $21.01 | $14.22 |
| Revenue Next Year | $17.59 | $3.77 |
| P/E Ratio | $62.55 | ★ $11.50 |
| Revenue Growth | ★ 2.47 | N/A |
| 52 Week Low | $64.99 | $51.18 |
| 52 Week High | $99.50 | $68.73 |
| Indicator | ANIP | EFSC |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 56.72 |
| Support Level | $79.69 | $52.48 |
| Resistance Level | $83.66 | $68.13 |
| Average True Range (ATR) | 2.06 | 1.42 |
| MACD | 0.07 | -0.11 |
| Stochastic Oscillator | 55.39 | 78.51 |
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Its Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.